Items where authors include "Dold, C."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 6.

Article

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine. ISSN 1078-8956

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29 (7). pp. 1760-1774. ISSN 1078-8956

Moore, S.C. orcid.org/0000-0001-8610-2806, Kronsteiner, B., Longet, S. et al. (61 more authors) (2023) Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. Med, 4 (3). 191-215.e9. ISSN 2666-6340

Shankar, S., Beckett, J., Tipton, T. et al. (23 more authors) (2022) SARS-CoV-2-specific T cell responses are not associated with protection against reinfection in hemodialysis patients. Journal of the American Society of Nephrology, 33 (5). pp. 883-887. ISSN 1046-6673

Ramasamy, M.N., Minassian, A.M., Ewer, K.J. et al. (418 more authors) (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396 (10267). pp. 1979-1993. ISSN 0140-6736

Adams, E.R., Ainsworth, M., Anand, R. et al. (69 more authors) (2020) Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel [version 1; peer review: 2 approved]. Wellcome Open Research, 5. 139. ISSN 2398-502X

This list was generated on Sat Apr 27 13:54:27 2024 BST.